Latest FN Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Christopher Rolland | Susquehanna | Maintains | Buy | $850.00 → $600.00 −250.00 (−29.4%) | |
| Dave Kang | B Riley | Maintains | Hold | $598.00 → $431.00 −167.00 (−27.9%) | |
| Aniruddha Ganguly | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Tim Savageaux | Northland | Reiterates | Buy | $800.00 | |
| Nilanshi Mukherjee | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Om Jaiswal | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Steven Fox | Fox Advisors | Upgrades | Buy | - | |
| Luke Lango John Kilhefner | InvestorPlace | Initiates Coverage | Buy | - | |
| Christopher Rolland | Susquehanna | Reiterates | Buy | $850.00 | |
| Tim Long | Barclays | Maintains | Buy | $702.00 → $739.00 +37.00 (+5.3%) | |
| Joseph Cardoso | JP Morgan | Reiterates | Hold | $680.00 → $695.00 +15.00 (+2.2%) | |
| Dave Kang | B Riley | Initiates | Hold | $635.00 → $598.00 −37.00 (−5.8%) | |
| Ryan Koontz | Needham | Maintains | Buy | $650.00 | |
| Michael Genovese | Rosenblatt | Reiterates | Buy | $750.00 |
